Top Markets
#1 DogBull DogBull +104.12%
#2 Siacoin Siacoin +53.82%
#3 UnifAI Network UnifAI Network +49.44%
#4 MarsCoin MarsCoin +48.42%
#5 ADO Protocol ADO Protocol +45.84%
#6 Ontology Gas Ontology Gas +25.12%
#7 Magma Finance Magma Finance +21.20%
#8 Useless Coin Useless Coin +21.16%
#9 Cash Cat Cash Cat +17.97%
#10 Apertum Apertum +13.03%
Coin of the day
DogBull DogBull
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Opus Genetics, Inc. Opus Genetics, Inc.

Opus Genetics, Inc.

IRD
Classement en actions #16218
Opus Genetics, Inc. is a clinical-stage biopharmaceutical company focused on... Opus Genetics, Inc. is a clinical-stage biopharmaceutical company focused on ophthalmology. The company is dedicated to discovering and commercializing innovative therapies to address significant unmet medical needs in patients suffering from refractive and retinal eye disorders. Its portfolio includes Phentolamine Ophthalmic Solution, currently used to reverse pharmacologically induced mydriasis (pupil dilation). This solution is also advancing through Phase III clinical trials for the treatment of presbyopia and impaired vision in dim light or at night. A leading candidate in its retinal pipeline is APX3330, a small-molecule inhibitor targeting the reduction oxidation effector factor-1 protein. APX3330 has successfully completed Phase II clinical trials for diabetic retinopathy. Furthermore, Opus Genetics is developing APX2009 and APX2014, two preclinical product candidates also aimed at various retinal indications. Originally founded in 2018 as Ocuphire Pharma, Inc., the company maintains its headquarters in Farmington Hills, Michigan.
Prix de l'action
$3.70
Dernière synchronisation: 2026-07-31
Capitalisation boursière
$305.87M
Changement (1 jour)
-3.53%
Changement (1 an)
203.66%
Pays
US
Échange Opus Genetics, Inc. (IRD)

Catégorie

Healthcare
Le prix IRD avec la capitalisation boursière de B
Opus Genetics, Inc. Opus Genetics, Inc.
IRD
$3.70
Capitalisation boursière de Opus Genetics, Inc.(IRD)
Capitalisation boursière: $305.87M
En September 2026, Opus Genetics, Inc. a une capitalisation boursière de $305.87M. Cela fait de Opus Genetics, Inc. la 16218th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Opus Genetics, Inc. du 2024 au 2026
IRD par rapport au top 5 des plus populaires stocks
Prix pour IRD L’actif B La capitalisation boursière de B Résultats
Opus Genetics, Inc. Opus Genetics, Inc.
$63,702.01 $305.87M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.260T +1,719,438.14%
Opus Genetics, Inc. Opus Genetics, Inc.
$57,875.41 $305.87M
Apple Inc. Apple Inc.
AAPL
$4.779T +1,562,157.96%
Opus Genetics, Inc. Opus Genetics, Inc.
$48,648.95 $305.87M
Alphabet Inc. Alphabet Inc.
GOOG
$4.017T +1,313,103.81%
Opus Genetics, Inc. Opus Genetics, Inc.
$45,046.59 $305.87M
Microsoft Corporation Microsoft Corporation
MSFT
$3.719T +1,215,863.74%
Opus Genetics, Inc. Opus Genetics, Inc.
$33,115.87 $305.87M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.734T +893,812.25%